NO930088D0 - 4-alkylimidazolderivater - Google Patents

4-alkylimidazolderivater

Info

Publication number
NO930088D0
NO930088D0 NO1993930088A NO930088A NO930088D0 NO 930088 D0 NO930088 D0 NO 930088D0 NO 1993930088 A NO1993930088 A NO 1993930088A NO 930088 A NO930088 A NO 930088A NO 930088 D0 NO930088 D0 NO 930088D0
Authority
NO
Norway
Prior art keywords
alkylimidazolderivater
angiotensin
potency
cooh
cho
Prior art date
Application number
NO1993930088A
Other languages
English (en)
Other versions
NO303015B1 (no
NO930088L (no
Inventor
David John Carini
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO930088L publication Critical patent/NO930088L/no
Publication of NO930088D0 publication Critical patent/NO930088D0/no
Publication of NO303015B1 publication Critical patent/NO303015B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO930088A 1990-07-13 1993-01-11 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive 4-alkylimidazolderivater NO303015B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55263790A 1990-07-13 1990-07-13
US07/650,258 US5137902A (en) 1990-07-13 1991-02-04 4-alkylimidazole derivatives and anti-hypertensive use thereof
PCT/US1991/004826 WO1992000977A2 (en) 1990-07-13 1991-07-15 4-alkylimidazole derivatives

Publications (3)

Publication Number Publication Date
NO930088L NO930088L (no) 1993-01-11
NO930088D0 true NO930088D0 (no) 1993-01-11
NO303015B1 NO303015B1 (no) 1998-05-18

Family

ID=27070086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930088A NO303015B1 (no) 1990-07-13 1993-01-11 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive 4-alkylimidazolderivater

Country Status (23)

Country Link
US (1) US5137902A (no)
EP (1) EP0539509B1 (no)
JP (1) JP2550455B2 (no)
KR (1) KR0162669B1 (no)
AT (1) ATE121087T1 (no)
AU (1) AU639400B2 (no)
BG (1) BG61341B1 (no)
CA (1) CA2087274C (no)
CZ (1) CZ280018B6 (no)
DE (1) DE69108913T2 (no)
DK (1) DK0539509T3 (no)
ES (1) ES2071325T3 (no)
FI (1) FI102752B1 (no)
HU (2) HUT63411A (no)
IE (1) IE69849B1 (no)
IL (1) IL98794A (no)
MY (1) MY140243A (no)
NO (1) NO303015B1 (no)
NZ (1) NZ238920A (no)
PL (1) PL168311B1 (no)
RO (1) RO111270B1 (no)
SK (1) SK279326B6 (no)
WO (1) WO1992000977A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4132633A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Cyclisch substituierte imidazolyl-propensaeurederivate
US5250558A (en) * 1992-01-28 1993-10-05 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
US5326776A (en) * 1992-03-02 1994-07-05 Abbott Laboratories Angiotensin II receptor antagonists
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
NO304429B1 (no) * 1992-12-17 1998-12-14 Sankyo Co Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
US5338740A (en) * 1993-07-13 1994-08-16 Pfizer Inc. Angiotensin II receptor antagonists
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
AU2001267404A1 (en) * 2000-05-04 2001-11-12 Ipf Pharmaceuticals Gmbh Novel compounds for the treatment of inflammatory and cardiovascular diseases
CA2568640C (en) 2004-06-04 2011-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CA2575177A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Purification of olmesartan medoxomil
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
AU645022B2 (en) * 1989-06-30 1994-01-06 E.I. Du Pont De Nemours And Company Fused-ring aryl substituted imidazoles
AU644802B2 (en) * 1989-06-30 1993-12-23 E.I. Du Pont De Nemours And Company Substituted imidazoles
DE4132633A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Cyclisch substituierte imidazolyl-propensaeurederivate

Also Published As

Publication number Publication date
AU8311691A (en) 1992-02-04
FI102752B (fi) 1999-02-15
IL98794A0 (en) 1992-07-15
KR0162669B1 (ko) 1998-12-01
BG97438A (bg) 1994-03-24
NO303015B1 (no) 1998-05-18
RO111270B1 (ro) 1996-08-30
FI102752B1 (fi) 1999-02-15
CA2087274A1 (en) 1992-01-14
BG61341B1 (en) 1997-06-30
DE69108913D1 (de) 1995-05-18
IE69849B1 (en) 1996-10-02
SK279326B6 (sk) 1998-10-07
US5137902A (en) 1992-08-11
CZ280018B6 (cs) 1995-09-13
MY140243A (en) 2009-12-31
AU639400B2 (en) 1993-07-22
DK0539509T3 (da) 1995-07-03
ES2071325T3 (es) 1995-06-16
PL168311B1 (pl) 1996-02-29
WO1992000977A2 (en) 1992-01-23
JP2550455B2 (ja) 1996-11-06
DE69108913T2 (de) 1995-08-24
EP0539509B1 (en) 1995-04-12
IL98794A (en) 1995-11-27
SK391292A3 (en) 1993-07-07
FI930109A0 (fi) 1993-01-12
IE912438A1 (en) 1992-01-15
ATE121087T1 (de) 1995-04-15
HU9204058D0 (en) 1993-03-29
NO930088L (no) 1993-01-11
PL297616A1 (no) 1992-07-13
WO1992000977A3 (en) 1992-02-20
NZ238920A (en) 1993-07-27
CA2087274C (en) 2002-02-19
HUT63411A (en) 1993-08-30
EP0539509A1 (en) 1993-05-05
HU223530B1 (hu) 2004-08-30
FI930109A (fi) 1993-01-12
CZ391292A3 (en) 1993-12-15
JPH05508415A (ja) 1993-11-25

Similar Documents

Publication Publication Date Title
NO930088L (no) 4-alkylimidazolderivater
DE69620443T2 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
LU91205I2 (fr) Ciclesonide et ses dérivés pharmaceutiquement acceptables (alvesco)
DE69325732D1 (de) Festkörper-Kondensatormikrofon
FI930970A (fi) Imidazolderivat med bifenylsulfonylurea- eller bifenylsulfonyluretansidokedja, foerfaranden foer framstaellning av dessa och anvaendning av dessa
NO20033184D0 (no) Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
DE69100517D1 (de) Polyethyleneiminphosphonatderivate als Dispergiermittel enthaltende Zementzusammensetzungen.
FI912963A (fi) Hjaernverksamheten oekande pyrimidinylderivat.
MX9201635A (es) Derivados de indol y di hidro quinolina.
FI930092A0 (fi) Indanopyrrolidinkarbamater
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
LU88789I2 (fr) Mésylate de tirilazad et ses dérivés pharmaceutiquement acceptables (Freedox (R))
KR920007932U (ko) 진공증착기의 절첩형 셔터
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
DK0582977T3 (da) Fremgangsmåde til fremstilling af 1,3-dialkyl-5-hydroxyoxindoler og etherderivater deraf
FR2659027B1 (fr) Castelet d'ombres chinoises.
FI914087A0 (fi) Foerfarande och anordning foer detektering av verktygshaverier i skaerande bearbetning.
KR910021272U (ko) 비디오 카메라의 뷰파인더(view finder) 고정장치
FI970397A0 (fi) Substituoituja 1,4-dihydroksylopent(b)indol-3(2H)-onijohdannaisia
KR910010198U (ko) 팩시밀리의 어스플레이트(earth plate)고정장치

Legal Events

Date Code Title Description
MK1K Patent expired